{
  "id": 16746080,
  "title": "Novartis raised its profit outlook even as a drug trial failure led to a $1.9 billion charge",
  "url": "https://urgent.news/2026/10/27/novartis-raised-its-profit-outlook-even-as-a-drug-trial-failure-led",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-27T12:00:45.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/novartis-raises-profit-outlook-trial-failure-charge-102726"
  },
  "original_language": "en",
  "account": null,
  "summary": "Core operating income guidance moved from a low-single-digit decline to flat or low-single-digit growth; net income fell 70%",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}